Vice President, Investor Relations & Communications

Vice President, Investor Relations & Communications

Join to apply for the Vice President, Investor Relations & Communications role at C4 Therapeutics, Inc.

C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical‑stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small‑molecule medicines to address difficult‑to‑treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease‑causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.

For more information, please visit

As C4T’s Vice President, Investor Relations & Communications, you will lead our external investor strategies and communications activities, ensuring consistent messaging across all platforms to all stakeholders, both internal and external. Reporting to the CFO and Head of Corporate Affairs, this position will lead the development, implementation and management of a comprehensive investor relations (IR) and external communications strategy, managing relationships with the investment community, including investors and sell‑side analysts.

You will also lead the corporate communications function, including corporate visibility, media and public relations (PR), and alignment with corporate strategy, as well as overseeing our internal communications function.

• รุះ ฉ